C-NRX

V:NRX - NurExone Biologic Inc. - http://www.nurexone.com

15:50:07 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
NRX - V	8.0	0.62	·	0.66	8.5	0.62	-0.03	-4.6	93.9	60	25	0.65 0.65 0.62	1.19 0.185	15:30:31	Apr 25	15 min RT 2¢
TSX-V - V	8.0	0.62	·	0.66	8.5	0.65			81.4	52	15	0.65 0.65 0.64	1.19 0.185	12:36:47		15 min
Omega - O						0.65			2.0	1	1	0.65 0.65 0.65		09:32:18		15 min
CX2 - H						0.62	-0.03	-4.6	10.2	6	7	0.65 0.65 0.62		15:30:31		15 min
CXD - D						0.65			0.001		1			Mar 05		15 min
TriAct - M						0.65			0.3	0	1					15 min

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
NOTE: Delayed ATS trade data is included - click System Status for more information

Show ATS · Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · Company · Participants · 1yr Bulletins · Sedar · Historical · Shorts · Portfolio

Recent Trades - Last 10 of 25

More trades...

Time ET	Ex	Price	Change	Volume	Buyer	Seller	Markers
15:30:31	H	0.62	-0.03	2,000	33 Canaccord	7 TD Sec	K
15:25:44	H	0.62	-0.03	1,000	33 Canaccord	7 TD Sec	K
15:25:44	H	0.63	-0.02	2,000	124 Questrade	7 TD Sec	K
15:21:40	H	0.63	-0.02	2,500	124 Questrade	7 TD Sec	K
15:21:40	H	0.63	-0.02	500	1 Anonymous	7 TD Sec	K
12:36:47	V	0.65		3,500	124 Questrade	1 Anonymous	K
12:34:22	V	0.65		2,000	1 Anonymous	1 Anonymous	K
12:34:12	V	0.65		4,500	85 Scotia	1 Anonymous	K
12:34:12	V	0.65		16,500	85 Scotia	33 Canaccord	K
12:34:12	H	0.65		243	85 Scotia	7 TD Sec	E

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Date ET	Symbol	Price	Type	Headline
2024-04-25 12:45	C:NRX	0.63	News Release200	Nurexone Biologic begins trading on OTCQB
2024-04-02 13:17	C:NRX	0.78	News Release200	Nurexone spends $1.54-million (U.S.) on R&D in 2023
2024-04-02 08:53	C:NRX	0.78	SEDAR Audited Annual Financial Statements804	SEDAR Audited Annual Financial Statements
2024-04-02 08:18	C:NRX	0.78	SEDAR MD & A815	SEDAR MD & A
2024-03-27 17:18	C:NRX	0.76	News Release200	Nurexone receives $3.95-million from warrant exercise
2024-03-22 17:17	C:NRX	0.65	News Release200	Nurexone signs deal with Vivox to test Exopten
2024-03-15 16:12	C:NRX	0.74	News Release200	Nurexone shares to list on OTCQB Venture Market
2024-03-08 16:11	C:NRX	0.82	News Release200	Nurexone finalizes lease for Israeli R&D facility
2024-02-20 16:27	C:NRX	1.09	News Release200	Nurexone expands IP portfolio with ExoTherapy platform
2024-02-14 16:34	C:NRX	0.48	News Release200	Nurexone to try to license ExoTherapy
2024-02-02 16:14	C:NRX	0.305	News Release200	Nurexone starts European regulatory process for ExoPTEN
2024-01-17 13:20	C:NRX	0.265	News Release200	Nurexone begins spinal cord research with Inteligex
2024-01-16 18:58	C:NRX	0.265	Private Placement250	Nurexone Biologic 7,091,993-share private placement
2024-01-05 09:37	C:NRX	0.295	News Release200	Nurexone closes $1.98-million private placement
2023-11-29 14:25	C:NRX	0.31	News Release200	Nurexone Biologic develops 2 RNA sequences
2023-11-24 09:51	C:NRX	0.31	News Release200	Nurexone spends $400,000 (U.S.) on R&D in Q3 2023
2023-11-24 08:08	C:NRX	0.31	SEDAR Interim MD & A813	SEDAR Interim MD & A
2023-11-24 08:06	C:NRX	0.31	SEDAR Interim Financial Statements812	SEDAR Interim Financial Statements
2023-10-30 09:33	C:NRX	0.31	News Release200	Nurexone receives orphan drug designation for ExoPTEN
2023-10-19 13:32	C:NRX	0.295	News Release200	Nurexone adds Dagi to scientific advisory board

Date ET

Symbol

Price

Type

Headline

2024-04-25 12:45

C:NRX

0.63

News Release

Nurexone Biologic begins trading on OTCQB

2024-04-02 13:17

C:NRX